HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCW Biologics is trading 6.8% down today as XBI declines 2.11%
HCW Biologics is trading 6.8% down now at $2.05 amid broad biotech weakness and a wider risk-off market. - The XBI sector ETF declines 2.11%, while higher...
🟢 HCW Biologics is trading 6.7% up in after-hours trading with no confirmed company-specific catalyst
HCW Biologics is trading at $2.39, up 6.70% after the regular-session close, with no confirmed September 11 company-specific catalyst identified. - Latest...
🔴 HCW Biologics is trading 5.35% down today amid continued selling pressure
HCW Biologics is trading 5.35% down at $2.30 amid continued selling pressure following declines of 14.63% on September 8 and 14.46% on September 3. - No clear...
🟢 HCW Biologics is trading 5% up in pre-market after recent selling pressure
HCW Biologics is trading 5.04% up at $2.58, rebounding after recent selling pressure. - It rebounded from the September 9 close of $2.46 after a sharp...
HCW Biologics Shares Crater 34% in a Week as Insider Resale Filing Piles Pressure on a Stock Already Reeling — Is There a Floor?
Shares of HCW Biologics slid another 8.8% to $2.29 on September 9, extending a punishing week that has erased roughly a third of the stock's value since...
🔴 HCW Biologics is trading 8.76% down in pre-market after shareholders filed to resell 1.24 million shares
HCW Biologics is trading 8.76% down in pre-market at $2.29 after existing shareholders filed to potentially resell up to 1,237,364 shares. - The company is...
🟢 HCW Biologics is trading 6.77% up in after-hours trading after Akron Biotech distribution deal
HCW Biologics is trading 6.77% up at $2.68 in after-hours trading after announcing an exclusive distribution agreement with Akron Biotech for HCW11-006. - The...
🔴 HCW Biologics is trading 14.97% down today; no verified catalyst identified
HCW Biologics is trading 14.97% down now at $2.50 after no verified September 8, 2026 company-specific catalyst was identified. - The latest confirmed...
🔴 HCW Biologics is trading 10.47% down in pre-market — no verified company-specific catalyst identified
HCW Biologics is trading 10.47% down now at $2.63 after no verified September 8, 2026 company-specific catalyst was identified. - The latest confirmed...
🔴 HCW Biologics is trading 7.13% down in pre-market as no verified catalyst was identified
HCW Biologics is trading 7.13% down at $2.73 with no verified September 8, 2026 company-specific catalyst identified. - The latest confirmed announcement was...
🟢 HCW Biologics is trading 14.56% up in pre-market; no verified company-specific catalyst identified
HCW Biologics is trading at $3.37, up +14.56%, with no verified September 8, 2026 company-specific catalyst identified. • The latest confirmed announcement...
🔴 HCW Biologics is trading 12.4% down today with no clear negative catalyst identified
HCW Biologics is trading 12.4% down now at $2.94, with no clear company-specific negative catalyst identified for September 3, 2026. - The decline continues a...
🔴 HCW Biologics is trading 5.81% down today — no company-specific catalyst identified
HCW Biologics is trading at $3.16, down 5.81% during the open session, with no new negative company-specific catalyst or explicit explanation identified for...
🔴 HCW Biologics is trading 5.81% down in after-hours trading — decline unexplained
HCW Biologics is trading at $3.16 (-5.81%) after the September 2, 2026 news announcement, though the after-hours decline is unexplained. - It closed at $3.35...
🟢 HCW Biologics is trading 6.67% up today as XBI gains 2.75%
HCW Biologics is trading at $3.68 (+6.67%) on September 2, 2026, as broader biotechnology sentiment remains supportive, with XBI up 2.75%. - No newly reported...
🟢 HCW Biologics is trading 7.55% up in pre-market with no fresh company-specific catalyst identified
HCW Biologics is trading 7.55% up now at $3.71 after a strong multi-session rally, though no definitive catalyst has been identified for September 2, 2026. -...
🔴 HCW Biologics is trading 5% down today after profit-taking following a sharp multi-session rally
HCW Biologics is trading 5.01% down now at $3.41, with apparent profit-taking adding pressure after a sharp multi-session rally. - Shares rose from $2.18 on...
🔴 HCW Biologics is trading 5.3% down in pre-market amid apparent profit-taking after consecutive gains
HCW Biologics is trading at $3.40, down 5.29% in pre-market amid apparent profit-taking after a sharp multi-session rally. - No new company-specific...
🔴 HCW Biologics is trading 7% down in after-hours trading after sharp multi-session rally
HCW Biologics is trading 6.96% down at $3.34 in after-hours trading, possibly reflecting profit-taking following a sharp multi-session rally. - No...
🔴 HCW Biologics is trading 5.25% down today after a sharp multi-session rally
HCW Biologics is trading 5.25% down at $3.25 after a sharp multi-session rally. - Shares gained 17.41% on August 27 and 8.20% on August 28. - No...